Table 2.
Therapeutic agent | Target | Tumor model | Effect on vessel diameter/density (refs.) | Effect on perfusion (refs.) |
Diptheria toxin | Cancer cells | Soft tissue sarcoma | ↑ (24) | Not reported |
Taxane | Cancer cells | Soft tissue sarcoma | ↑ (23) | Not reported |
Saridegib | Stromal cells | Pancreatic ductal carcinoma | ↑ (25, 27) | ↑ (25, 27) |
PEGPH20 | Hyaluronan | Pancreatic ductal carcinoma | ↑ (28, 29) | ↑ (28, 29) |
1D11 | Collagen | Mammary carcinoma | ↑ (30) | ↑ (30) |
Losartan | Stromal cells, hyaluronan, collagen | Pancreatic ductal carcinoma | ↑ (26) | ↑ (26) |
Diphtheria toxin is preferentially toxic to human cancer cells and thus preferentially kills cancer cells in a human tumor xenograft model. Taxane is a chemotherapeutic agent. Saridegib is an inhibitor of the Hedgehog cellular signaling pathway. PEGPH20 is a PEGylated human recombinant hyaluronidase. 1D11 is a TGF-β neutralizing antibody. Losartan is an angiotensin receptor blocker.